BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15941823)

  • 1. Venous thromboembolism prevention in acutely ill nonsurgical patients.
    Brophy DF; Dougherty JA; Garrelts JC; Parish RC; Rivey MP; Stumpf JL; Taylor CT; Mathis AS
    Ann Pharmacother; 2005; 39(7-8):1318-24. PubMed ID: 15941823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis.
    Själander A; Jansson JH; Bergqvist D; Eriksson H; Carlberg B; Svensson P
    J Intern Med; 2008 Jan; 263(1):52-60. PubMed ID: 18088252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism in the medically ill patient: a call to action.
    Bergmann JF; Kher A
    Int J Clin Pract; 2005 May; 59(5):555-61. PubMed ID: 15857352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis against venous thromboembolism in acutely ill medical patients: an observational study.
    Peterman CM; Kolansky DM; Spinler SA
    Pharmacotherapy; 2006 Aug; 26(8):1086-90. PubMed ID: 16863485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of venous thromboembolism in medically ill patients: a clinical update.
    Turpie AG; Leizorovicz A
    Postgrad Med J; 2006 Dec; 82(974):806-9. PubMed ID: 17148703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
    Kahn SR; Panju A; Geerts W; Pineo GF; Desjardins L; Turpie AG; Glezer S; Thabane L; Sebaldt RJ;
    Thromb Res; 2007; 119(2):145-55. PubMed ID: 16516275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of enoxaparin as prophylaxis against venous thromboembolism in seriously ill medical patients: a US perspective.
    de Lissovoy G; Subedi P
    Am J Manag Care; 2002 Dec; 8(12):1082-8. PubMed ID: 12500884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolic risk and its prevention in hospitalized medical patients.
    Haas SK
    Semin Thromb Hemost; 2002 Dec; 28(6):577-84. PubMed ID: 12536351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study.
    Alikhan R; Cohen AT; Combe S; Samama MM; Desjardins L; Eldor A; Janbon C; Leizorovicz A; Olsson CG; Turpie AG;
    Arch Intern Med; 2004 May; 164(9):963-8. PubMed ID: 15136304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism prophylaxis in medical patients: future perspectives.
    Imberti D; Prisco D
    Thromb Res; 2005; 116(5):365-75. PubMed ID: 16122549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choosing the appropriate antithrombotic agent for the prevention and treatment of VTE: a case-based approach.
    Nutescu EA; Wittkowsky AK; Dobesh PP; Hawkins DW; Dager WE
    Ann Pharmacother; 2006 Sep; 40(9):1558-71. PubMed ID: 16912250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates.
    Stinnett JM; Pendleton R; Skordos L; Wheeler M; Rodgers GM
    Am J Hematol; 2005 Mar; 78(3):167-72. PubMed ID: 15726600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients.
    McGarry LJ; Thompson D; Weinstein MC; Goldhaber SZ
    Am J Manag Care; 2004 Sep; 10(9):632-42. PubMed ID: 15515996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism prophylaxis conversion in nonsurgical inpatients.
    Carroll DN; Hudson EB
    Ann Pharmacother; 2003 Sep; 37(9):1194-6. PubMed ID: 12921498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism prevention in the acutely ill medical patient: a review of the literature and focus on special patient populations.
    Pendleton R; Wheeler M; Rodgers G
    Am J Hematol; 2005 Jul; 79(3):229-37. PubMed ID: 15981227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of venous thromboembolism in internal medicine and neurology].
    Malý J; Dulícek P; Penka M; Malý R; Gumulec J
    Vnitr Lek; 2006 Mar; 52 Suppl 1():63-7. PubMed ID: 16637452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism prophylaxis for the medical patient: where do we stand?
    Yavin Y; Cohen AT
    Semin Respir Crit Care Med; 2008 Feb; 29(1):75-82. PubMed ID: 18302089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolic prophylaxis in hospitalized medical patients.
    Stark JE; Kilzer WJ
    Ann Pharmacother; 2004 Jan; 38(1):36-40. PubMed ID: 14742790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.